232 related articles for article (PubMed ID: 20975209)
1. Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths.
Smit MA; Peeper DS
Aging (Albany NY); 2010 Oct; 2(10):735-41. PubMed ID: 20975209
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factors.
Ohashi S; Natsuizaka M; Wong GS; Michaylira CZ; Grugan KD; Stairs DB; Kalabis J; Vega ME; Kalman RA; Nakagawa M; Klein-Szanto AJ; Herlyn M; Diehl JA; Rustgi AK; Nakagawa H
Cancer Res; 2010 May; 70(10):4174-84. PubMed ID: 20424117
[TBL] [Abstract][Full Text] [Related]
3. A Novel Splice Variant of the Inhibitor of Growth 3 Lacks the Plant Homeodomain and Regulates Epithelial-Mesenchymal Transition in Prostate Cancer Cells.
Melekhova A; Leeder M; Pungsrinont T; Schmäche T; Kallenbach J; Ehsani M; Mirzakhani K; Rasa SMM; Neri F; Baniahmad A
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439818
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines.
De Amicis F; Perri A; Vizza D; Russo A; Panno ML; Bonofiglio D; Giordano C; Mauro L; Aquila S; Tramontano D; Andò S
J Cell Physiol; 2013 Oct; 228(10):2054-62. PubMed ID: 23553645
[TBL] [Abstract][Full Text] [Related]
5. ZEB proteins link cell motility with cell cycle control and cell survival in cancer.
Browne G; Sayan AE; Tulchinsky E
Cell Cycle; 2010 Mar; 9(5):886-91. PubMed ID: 20160487
[TBL] [Abstract][Full Text] [Related]
6. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.
Morel AP; Hinkal GW; Thomas C; Fauvet F; Courtois-Cox S; Wierinckx A; Devouassoux-Shisheboran M; Treilleux I; Tissier A; Gras B; Pourchet J; Puisieux I; Browne GJ; Spicer DB; Lachuer J; Ansieau S; Puisieux A
PLoS Genet; 2012; 8(5):e1002723. PubMed ID: 22654675
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Twist1-mediated invasion by Chk2 promotes premature senescence in p53-defective cancer cells.
Nayak D; Kumar A; Chakraborty S; Rasool RU; Amin H; Katoch A; Gopinath V; Mahajan V; Zilla MK; Rah B; Gandhi SG; Ali A; Kumar LD; Goswami A
Cell Death Differ; 2017 Jul; 24(7):1275-1287. PubMed ID: 28498365
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol induced premature senescence and inhibited epithelial-mesenchymal transition of cancer cells via induction of tumor suppressor Rad9.
Chen KY; Chen CC; Chang YC; Chang MC
PLoS One; 2019; 14(7):e0219317. PubMed ID: 31310624
[TBL] [Abstract][Full Text] [Related]
9. Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition.
Dave N; Guaita-Esteruelas S; Gutarra S; Frias À; Beltran M; Peiró S; de Herreros AG
J Biol Chem; 2011 Apr; 286(14):12024-32. PubMed ID: 21317430
[TBL] [Abstract][Full Text] [Related]
10. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells.
Bendinelli P; Maroni P; Matteucci E; Desiderio MA
Mol Cancer; 2015 Jun; 14():112. PubMed ID: 26041563
[TBL] [Abstract][Full Text] [Related]
11. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
12. The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?
Brabletz S; Brabletz T
EMBO Rep; 2010 Sep; 11(9):670-7. PubMed ID: 20706219
[TBL] [Abstract][Full Text] [Related]
13. Escape from p21-mediated oncogene-induced senescence leads to cell dedifferentiation and dependence on anti-apoptotic Bcl-xL and MCL1 proteins.
de Carné Trécesson S; Guillemin Y; Bélanger A; Bernard AC; Preisser L; Ravon E; Gamelin E; Juin P; Barré B; Coqueret O
J Biol Chem; 2011 Apr; 286(15):12825-38. PubMed ID: 21292770
[TBL] [Abstract][Full Text] [Related]
14. AKT-ions with a TWIST between EMT and MET.
Tang H; Massi D; Hemmings BA; Mandalà M; Hu Z; Wicki A; Xue G
Oncotarget; 2016 Sep; 7(38):62767-62777. PubMed ID: 27623213
[TBL] [Abstract][Full Text] [Related]
15. VentX trans-activates p53 and p16ink4a to regulate cellular senescence.
Wu X; Gao H; Ke W; Hager M; Xiao S; Freeman MR; Zhu Z
J Biol Chem; 2011 Apr; 286(14):12693-701. PubMed ID: 21325273
[TBL] [Abstract][Full Text] [Related]
16. A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma.
Caramel J; Papadogeorgakis E; Hill L; Browne GJ; Richard G; Wierinckx A; Saldanha G; Osborne J; Hutchinson P; Tse G; Lachuer J; Puisieux A; Pringle JH; Ansieau S; Tulchinsky E
Cancer Cell; 2013 Oct; 24(4):466-80. PubMed ID: 24075834
[TBL] [Abstract][Full Text] [Related]
17. Loss of BRG1 induces CRC cell senescence by regulating p53/p21 pathway.
Wang G; Fu Y; Hu F; Lan J; Xu F; Yang X; Luo X; Wang J; Hu J
Cell Death Dis; 2017 Feb; 8(2):e2607. PubMed ID: 28182012
[TBL] [Abstract][Full Text] [Related]
18. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
[TBL] [Abstract][Full Text] [Related]
19. Keratin 13 gene is epigenetically suppressed during transforming growth factor-β1-induced epithelial-mesenchymal transition in a human keratinocyte cell line.
Hatta M; Miyake Y; Uchida K; Yamazaki J
Biochem Biophys Res Commun; 2018 Feb; 496(2):381-386. PubMed ID: 29326042
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme 2 attenuates the metastasis of non-small cell lung cancer through inhibition of epithelial-mesenchymal transition.
Qian YR; Guo Y; Wan HY; Fan L; Feng Y; Ni L; Xiang Y; Li QY
Oncol Rep; 2013 Jun; 29(6):2408-14. PubMed ID: 23545945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]